Arcturus Therapeutics Holdings (ARCT) Revenue Growth (3y) (2021 - 2026)
Arcturus Therapeutics Holdings (ARCT) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.73% |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 122.97% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.94% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -70.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.50% |
| Dec 31, 2025 | -64.46% |
| Sep 30, 2025 | 8.66% |
| Jun 30, 2025 | 1.46% |
| Mar 31, 2025 | 77.61% |
| Dec 31, 2024 | 57.80% |
| Sep 30, 2024 | 157.63% |
| Jun 30, 2024 | 192.08% |
| Mar 31, 2024 | 161.45% |
| Dec 31, 2023 | 139.78% |
| Sep 30, 2023 | 168.46% |
| Jun 30, 2023 | 65.46% |
| Mar 31, 2023 | 211.90% |
| Dec 31, 2022 | 277.99% |
| Sep 30, 2022 | 59.13% |
| Jun 30, 2022 | 38.70% |
| Mar 31, 2022 | 6.43% |
| Dec 31, 2021 | -8.55% |
| Sep 30, 2021 | -10.71% |
| Jun 30, 2021 | -5.70% |